CoChat

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

Open access
Cao, Qiushi, Ge, Cheng, Wang, Xuejie, Harvey, Peta J, Zhang, Zixuan, Ma, Yuan, Wang, Xianghong, Jia, Xinying, Mobli, Mehdi, Craik, David J, Jiang, Tao, Yang, Jinbo, Wei, Zhiqiang, Wang, Yan, Chang, Shan, Yu, Rilei · 2023 · Briefings in Bioinformatics
Cited by 116

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

With the emergence of multidrug-resistant bacteria, antimicrobial peptides (AMPs) offer promising options for replacing traditional antibiotics to treat bacterial infections, but discovering and designing AMPs using traditional methods is a time-consuming and costly process. Deep learning has been applied to the de novo design of AMPs and address AMP classification with high efficiency. In this study, several natural language processing models were combined to design and identify AMPs, i.e. sequence generative adversarial nets, bidirectional encoder representations from transformers and multilayer perceptron. Then, six candidate AMPs were screened by AlphaFold2 structure prediction and molecular dynamic simulations. These peptides show low homology with known AMPs and belong to a novel class of AMPs. After initial bioactivity testing, one of the peptides, A-222, showed inhibition against gram-positive and gram-negative bacteria. The structural analysis of this novel peptide A-222 obtained by nuclear magnetic resonance confirmed the presence of an alpha-helix, which was consistent with the results predicted by AlphaFold2. We then performed a structure–activity relationship study to design a new series of peptide analogs and found that the activities of these analogs could be increased by 4–8-fold against Stenotrophomonas maltophilia WH 006 and Pseudomonas aeruginosa PAO1. Overall, deep learning shows great potential in accelerating the discovery of novel AMPs and holds promise as an important tool for developing novel AMPs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bib/bbad058

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 59

  1. Ventola, 2015, The antibiotic resistance crisis: part 1: causes and threats, P t, 40, 277
  2. Ma, 2022, Identification of antimicrobial peptides from the human gut microbiome using deep learning, Nat Biotechnol, 40, 921, 10.1038/s41587-022-01226-0 · DOI · Paper page
  3. Mishra, 2017, Host defense antimicrobial peptides as antibiotics: design and application strategies, Curr Opin Chem Biol, 38, 87, 10.1016/j.cbpa.2017.03.014 · DOI · Paper page
  4. Roncevic, 2019, Antimicrobial peptides as anti-infective agents in pre-post-antibiotic era?, Int J Mol Sci, 20, 5713, 10.3390/ijms20225713 · DOI
  5. Yu, 2018, Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics, Proc Biol Sci, 285, 20172687
  6. Zhang, 2016, Antimicrobial peptides, Curr Biol, 26, R14, 10.1016/j.cub.2015.11.017 · DOI · Paper page
  7. Lazzaro, 2020, Antimicrobial peptides: application informed by evolution, Science, 368, 487, 10.1126/science.aau5480 · DOI · Paper page
  8. Usmani, 2017, THPdb: database of FDA-approved peptide and protein therapeutics, PLoS One, 12, 10.1371/journal.pone.0181748 · DOI · Paper page
  9. Zhang, 2022, Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection, Brief Bioinform, 23, 1, 10.1093/bib/bbac468 · DOI
  10. Chen, 2020, NCMCMDA: miRNA–disease association prediction through neighborhood constraint matrix completion, Brief Bioinform, 22, 485, 10.1093/bib/bbz159 · DOI · Paper page
  11. Chen, 2020, Deep-belief network for predicting potential miRNA-disease associations, Brief Bioinform, 22, 1
  12. Lipinski, 2019, Advances and perspectives in applying deep learning for drug design and discovery, Front Robot AI, 6, 108, 10.3389/frobt.2019.00108 · DOI
  13. Gao, 2018, The modification and design of antimicrobial peptide, Curr Pharm Design, 24, 904, 10.2174/1381612824666180213130318 · doi:10.2174/1381612824666180213130318
  14. Das, 2021, Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations, Nat Biomed Eng, 5, 613, 10.1038/s41551-021-00689-x · DOI · Paper page
  15. Surana, 2021, PandoraGAN: generating antiviral peptides using generative adversarial network, 10.1101/2021.02.15.431193 · doi:10.1101/2021.02.15.431193
  16. Tucs, 2020, Generating ampicillin-level antimicrobial peptides with activity-aware generative adversarial networks, ACS Omega, 5, 22847, 10.1021/acsomega.0c02088 · DOI · Paper page
  17. Dean, 2021, PepVAE: variational autoencoder framework for antimicrobial peptide generation and activity prediction, Front Microbiol, 12, 10.3389/fmicb.2021.725727 · DOI · Paper page
  18. Liang, 2020, Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity, Biomater Sci, 8, 6858, 10.1039/D0BM00801J · DOI · Paper page
  19. Pinacho-Castellanos, 2021, Alignment-free antimicrobial peptide predictors: improving performance by a thorough analysis of the largest available data set, J Chem Inf Model, 61, 3141, 10.1021/acs.jcim.1c00251 · DOI
  20. Singh, 2022, StaBle-ABPpred: a stacked ensemble predictor based on biLSTM and attention mechanism for accelerated discovery of antibacterial peptides, Brief Bioinform, 23, 1, 10.1093/bib/bbab439 · DOI
  21. Jan, 2022, Target-AMP: computational prediction of antimicrobial peptides by coupling sequential information with evolutionary profile, Comput Biol Med, 151, 10.1016/j.compbiomed.2022.106311 · DOI
  22. Veltri, 2018, Deep learning improves antimicrobial peptide recognition, Bioinformatics, 34, 2740, 10.1093/bioinformatics/bty179 · DOI · Paper page
  23. Yan, 2022, sAMPpred-GAT: prediction of antimicrobial peptide by graph attention network and predicted peptide structure, Bioinformatics, 39, btac715, 10.1093/bioinformatics/btac715 · DOI · Paper page
  24. Hussain, 2022, sAMP-PFPDeep: improving accuracy of short antimicrobial peptides prediction using three different sequence encodings and deep neural networks, Brief Bioinform, 23, 1, 10.1093/bib/bbab487 · DOI
  25. Kha, 2022, Identifying SNARE proteins using an alignment-free method based on multiscan convolutional neural network and PSSM profiles, J Chem Inf Model, 62, 4820, 10.1021/acs.jcim.2c01034 · DOI
  26. Le, 2022, BERT-promoter: an improved sequence-based predictor of DNA promoter using BERT pre-trained model and SHAP feature selection, Comput Biol Chem, 99, 10.1016/j.compbiolchem.2022.107732 · DOI
  27. Naseer, 2021, Optimization of serine phosphorylation prediction in proteins by comparing human engineered features and deep representations, Anal Biochem, 615, 114069, 10.1016/j.ab.2020.114069 · DOI
  28. Lin, 2022, Language models of protein sequences at the scale of evolution enable accurate structure prediction, bioRxiv
  29. Sanches, 2021, Conformational dynamics in peptide toxins: implications for receptor interactions and molecular design, Toxicon, 201, 127, 10.1016/j.toxicon.2021.08.020 · DOI
  30. Cramer, 2021, AlphaFold2 and the future of structural biology, Nat Struct Mol Biol, 28, 704, 10.1038/s41594-021-00650-1 · DOI · Paper page
  31. Yokoo, 2021, Structure-activity relationship study of amphipathic antimicrobial peptides using helix-destabilizing sarcosine, J Pept Sci, 27, e3360, 10.1002/psc.3360 · doi:10.1002/psc.3360
  32. Hirano, 2020, Rational design of helix-stabilized antimicrobial peptide foldamers containing alpha,alpha-disubstituted amino acids or side-chain stapling, ChemPlusChem, 85, 2731, 10.1002/cplu.202000749 · DOI
  33. Lee, 2015, A large-scale structural classification of antimicrobial peptides, Biomed Res Int, 2015
  34. Gawde, 2022, CAMPR4: a database of natural and synthetic antimicrobial peptides, Nucleic Acids Res, 51, D377, 10.1093/nar/gkac933 · DOI · Paper page
  35. Aguilera-Mendoza, 2020, Automatic construction of molecular similarity networks for visual graph mining in chemical space of bioactive peptides: an unsupervised learning approach, Sci Rep, 10, 18074, 10.1038/s41598-020-75029-1 · DOI
  36. Sidorczuk, 2022, Benchmarks in antimicrobial peptide prediction are biased due to the selection of negative data, Brief Bioinform, 23, 1, 10.1093/bib/bbac343 · DOI
  37. Burdukiewicz, 2020, Proteomic screening for prediction and design of antimicrobial peptides with AmpGram, Int J Mol Sci, 21, 4310, 10.3390/ijms21124310 · DOI · Paper page
  38. Wang, 2016, APD3: the antimicrobial peptide database as a tool for research and education, Nucleic Acids Res, 44, D1087, 10.1093/nar/gkv1278 · DOI · Paper page
  39. Yu, 2017, 31st Association for the Advancement of Artificial Intelligence (AAAI) Conference on Artificial Intelligence, 2852
  40. García-Jacas, 2022, Handcrafted versus non-handcrafted (self-supervised) features for the classification of antimicrobial peptides: complementary or redundant?, Brief Bioinform, 23, 1, 10.1093/bib/bbac428 · DOI
  41. Laurens, 2008, Visualizing data using t-SNE, J Mach Learn Res, 9, 2579
  42. Yu, 2020, Enhanced activity against multidrug-resistant bacteria through coapplication of an analogue of tachyplesin I and an inhibitor of the QseC/B SIGNALING pathway, J Med Chem, 63, 3475, 10.1021/acs.jmedchem.9b01563 · doi:10.1021/acs.jmedchem.9b01563
  43. Shen, 2013, Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks, J Biomol NMR, 56, 227, 10.1007/s10858-013-9741-y · DOI · Paper page
  44. Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Crystallogr D Biol Crystallogr, 66, 12, 10.1107/S0907444909042073 · DOI · Paper page
  45. Maier, 2015, ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB, J Chem Theory Comput, 11, 3696, 10.1021/acs.jctc.5b00255 · DOI · Paper page
  46. Miyamoto, 2010, Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models, J Comput Chem, 13, 952, 10.1002/jcc.540130805 · DOI · Paper page
  47. Li, 2022, AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens, BMC Genomics, 23, 77, 10.1186/s12864-022-08310-4 · DOI · Paper page
  48. Santos-Júnior, 2020, Macrel: antimicrobial peptide screening in genomes and metagenomes, PeerJ, 8, 10.7717/peerj.10555 · DOI · Paper page
  49. Lawrence, 2020, amPEPpy 1.0: a portable and accurate antimicrobial peptide prediction tool, Bioinformatics, 37, 2058, 10.1093/bioinformatics/btaa917 · DOI · Paper page
  50. García-Jacas, 2022, Do deep learning models make a difference in the identification of antimicrobial peptides?, Brief Bioinform, 23, 1, 10.1093/bib/bbac094 · DOI
  51. Vincenzi, 2021, NMR spectroscopy in the conformational analysis of peptides: an overview, Curr Med Chem, 28, 2729, 10.2174/0929867327666200702131032 · DOI
  52. Benetti, 2019, NMR model structure of the antimicrobial peptide maximin 3, Eur Biophys J, 48, 203, 10.1007/s00249-019-01346-7 · DOI
  53. Greenfield, 2006, Using circular dichroism spectra to estimate protein secondary structure, Nat Protoc, 1, 2876, 10.1038/nprot.2006.202 · DOI · Paper page
  54. Migon, 2019, Alanine scanning studies of the antimicrobial peptide Aurein 1.2, probiotics Antimicrob, Proteins, 11, 1042
  55. Cantini, 2020, Effect of positive charges in the structural interaction of crabrolin isoforms with lipopolysaccharide, J Pept Sci, 26, e3271, 10.1002/psc.3271 · doi:10.1002/psc.3271
  56. Aschi, 2020, Structural characterization and biological activity of crabrolin peptide isoforms with different positive charge, BBA-Biomembranes, 1862, 10.1016/j.bbamem.2019.183055 · DOI
  57. Kerr, 2009, Pseudomonas aeruginosa: a formidable and ever-present adversary, J Hosp Infect, 73, 338, 10.1016/j.jhin.2009.04.020 · DOI · Paper page
  58. Torres, 2019, Peptide design principles for antimicrobial applications, J Mol Biol, 431, 3547, 10.1016/j.jmb.2018.12.015 · DOI · Paper page
  59. Trifonova, 2019, Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors, Infect Dis, 51, 168, 10.1080/23744235.2018.1531145 · DOI

Cited by

Metadata

Authors
Cao, Q., Ge, C., Wang, X., Harvey, P. J., Zhang, Z., Ma, Y., Wang, X., Jia, X., Mobli, M., Craik, D. J., Jiang, T., Yang, J., Wei, Z., Wang, Y., Chang, S., & Yu, R.
Venue
Briefings in Bioinformatics
Published
2023-03-01
Volume
24
Issue
2
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W4322718303
Cited by
116
References
7
FWCI
16.95
Type
journal article
Language
en
Open access
bronze
Funders
  • National Natural Science Foundation of China (82122064, 32171267, 42176108)
  • National Science and Technology Major Project for Significant New Drugs Development (2018ZX09735004)
  • Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science (CE200100012)
  • National Health and Medical Research Council (2009564)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.